Synonyms: compound A-1 [WO2022023450]
Compound class:
Synthetic organic
Comment: The chemical structure for flezurafenib was obtained from proposed INN list 130 (Feb. 2024), in which the compound is described as a rapidly accelerated fibrosarcoma (Raf) kinase inhibitor with proposed antineoplastic action. It is one of the Raf inhibitors claimed in patent WO2022023450A1 [1]. Investigation of Jazz Pharmaceuticals' pipeline suggests that flezurafenib may be their oral pan-Raf inhibitor clinical lead JZP815. This lead is being explored for efficacy against solid tumours and haematologic malignancies harbouring oncogenic mutations that activate the RAS-RAF-MAPK pathway. We will update this entry when the structure for flezurafenib or JZP815 is publicly disclosed.
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
5-[[(3S)-3-[5-(4-fluorophenyl)-1H-imidazol-2-yl]-3,4-dihydro-2H-chromen-6-yl]oxy]-3,4-dihydro-1H-1,8-naphthyridin-2-one |
International Nonproprietary Names | |
INN number | INN |
12891 | flezurafenib |
Synonyms |
compound A-1 [WO2022023450] |
Database Links | |
CAS Registry No. | 2760321-00-2 (source: WHO INN record) |
GtoPdb PubChem SID | 491300015 |
PubChem CID | 162772363 |
Search Google for chemical match using the InChIKey | TWJSMWXWCWQPRO-QGZVFWFLSA-N |
Search Google for chemicals with the same backbone | TWJSMWXWCWQPRO |
Search PubMed clinical trials | flezurafenib |
Search PubMed titles | flezurafenib |
Search PubMed titles/abstracts | flezurafenib |
UniChem Compound Search for chemical match using the InChIKey | TWJSMWXWCWQPRO-QGZVFWFLSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | TWJSMWXWCWQPRO-QGZVFWFLSA-N |